Please login to the form below
eClinical
This page shows the latest eClinical news and features for those working in and with pharma, biotech and healthcare.
Taking contract research’s pulse
The eClinical Trial market continues to evolve with an increase in the number of software applications and informatics tools for managing the clinical trials process, although at the moment these independent ... However, significant progress is being
Latest news
-
PharmaPros re-brands as eClinical Insights
Clinical trial technology company PharmaPros has changed its name to eClinical Insights to better align itself with industry trends. ... President and CEO Peg Regan said: “The transition into eClinical Insights has been a natural evolution, and has
-
Department of Health announces draft NHS constitution
Every provider of NHS services will need to systematically measure, analyse and improve quality, displaying it to staff through ëclinical dashboards' to measure their performance and use the information to make
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Transforming clinical trial data into a long-term asset
Our survey found that no fewer than 90% of sponsors and CROs have already adopted an eClinical application to improve study execution and data collection in live trials, while 36% of ... of CRO respondents admitted to being unable to convert documents
-
Pushing the accelerator
How eClinical technologies can speed up the drug development process. Though our understanding of human biology and medicine has increased tremendously over the past decade, the pace at which drugs are ... By some estimates, an integrated eClinical
Transforming clinical trial data into a long-term asset
Pushing the accelerator
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Augmented Reality in patient communication – don’t miss out!
There are many advantages to an electronic data capture approach, but one example I found particularly interesting was from Canadian based eClinical solution provider, Axiom Metrics, who state on their website
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Medical Editor
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Associate Account Director
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Medical Writer
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Publications Director
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Merck & Co reveals plans for women’s health spinoff Organon
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- bluebird bio aiming to separate business units by year-end
- FDA accepts BMS’ investigational cardiovascular drug mavacamten for review
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- Clark Health promotes Siân Hurst to managing director role
- ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Merck & Co reveals plans for women’s health spinoff Organon
- Virtual agency The Difference Collective makes new hires to senior team
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- The impact of cancer on mental health during COVID-19
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
